Inherited lipid metabolism disorder
MONDO:0002525An inherited metabolic disorder caused by an enzyme deficiency, resulting in an inability to oxidize fatty acids for energy production.
Also known as: disorder of lipid metabolism, dyslipidaemia, dyslipidemia, lipid metabolism disorder, fatty acid metabolism disorder
644 clinical trials for this condition and its sub-types, 201 tagged with Inherited lipid metabolism disorder itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Inherited lipid metabolism disorder
-
Lysosomal lipid storage disorder 2 trials · 192 incl. sub-types
7 sub-types
- Sphingolipidosis 6 trials · 166 incl. sub-types Sub-types →
- Cerebral lipidosis with dementia 0 trials · 38 incl. sub-types Sub-types →
- Neuronal ceroid lipofuscinosis 6 trials · 23 incl. sub-types Sub-types →
- Xanthomatosis 2 trials · 8 incl. sub-types Sub-types →
- Lysosomal acid lipase deficiency 4 trials · 6 incl. sub-types Sub-types →
- Neutral lipid storage disease 1 trial · 2 incl. sub-types Sub-types →
- Triglyceride storage disease 0 trials Sub-types →
-
Familial hyperlipidemia 8 trials · 130 incl. sub-types
10 sub-types
- Familial hypercholesterolemia 58 trials · 94 incl. sub-types Sub-types →
- Hyperlipidemia, familial combined, LPL related 22 trials
- Familial lipoprotein lipase deficiency 6 trials
- Hyperlipoproteinemia type 3 4 trials
- Hyperlipoproteinemia type V 2 trials
- Cholesterol-ester transfer protein deficiency 0 trials
- Familial apolipoprotein C-II deficiency 0 trials
- Hyperlipidemia due to hepatic triglyceride lipase deficiency 0 trials
- Hyperlipidemia, combined, 2 0 trials
- Hyperlipoproteinemia, type 1D 0 trials
-
Syndromic dyslipidemia 0 trials · 73 incl. sub-types
29 sub-types
- CHILD syndrome 37 trials
- Smith-Lemli-Opitz syndrome 6 trials
- Cerebrotendinous xanthomatosis 6 trials
- Familial lipoprotein lipase deficiency 6 trials
- Lysosomal acid lipase deficiency 4 trials · 6 incl. sub-types Sub-types →
- Barth syndrome 5 trials
- Mevalonate kinase deficiency 3 trials · 4 incl. sub-types Sub-types →
- GM1 gangliosidosis type 1 3 trials
- Sjogren-Larsson syndrome 3 trials
- Nephrotic syndrome 14 3 trials
- Apparent mineralocorticoid excess 1 trial
- Neuronal ceroid lipofuscinosis 8 northern epilepsy variant 1 trial
- Peroxisome biogenesis disorder due to PEX5 defect in the PEX7-binding domain 0 trials · 1 incl. sub-types Sub-types →
- Rhizomelic chondrodysplasia punctata type 1 1 trial
- CHIME syndrome 0 trials
- Krabbe disease due to saposin A deficiency 0 trials
- PHARC syndrome 0 trials
- Autosomal recessive complex spastic paraplegia due to kennedy pathway dysfunction 0 trials
- Congenital ichthyosis-intellectual disability-spastic quadriplegia syndrome 0 trials
- Familial apolipoprotein C-II deficiency 0 trials
- Fatty acid hydroxylase-associated neurodegeneration 0 trials
- Hereditary spastic paraplegia 39 0 trials Sub-types →
- Hyperlipoproteinemia, type 1D 0 trials
- Hyperphosphatasia-intellectual disability syndrome 0 trials Sub-types →
- Intellectual disability, autosomal recessive 53 0 trials
- Lipoprotein glomerulopathy 0 trials
- Multiple congenital anomalies-hypotonia-seizures syndrome 2 0 trials
- Sea-blue histiocyte syndrome 0 trials
- Sitosterolemia 0 trials Sub-types →
-
Sterol metabolism disorder 0 trials · 60 incl. sub-types
4 sub-types
- Sterol biosynthesis disorder 0 trials · 45 incl. sub-types Sub-types →
- Cholesterol metabolism disease 3 trials · 13 incl. sub-types Sub-types →
- Inborn disorder of bile acid synthesis 2 trials · 12 incl. sub-types Sub-types →
- Recessive X-linked ichthyosis 2 trials Sub-types →
-
Steroid inherited metabolic disorder 0 trials · 39 incl. sub-types
3 sub-types
- Congenital adrenal hyperplasia 36 trials · 38 incl. sub-types Sub-types →
- Congenital bile acid synthesis defect 1 trial · 2 incl. sub-types Sub-types →
- Apparent mineralocorticoid excess 1 trial
-
Inherited fatty acid metabolism disorder 7 trials · 21 incl. sub-types
3 sub-types
- Disorder of fatty acid oxidation and ketogenesis 1 trial · 16 incl. sub-types Sub-types →
- Carnitine palmitoyl transferase 1A deficiency 1 trial
- Inherited lipoic acid biosynthesis defect 0 trials · 1 incl. sub-types Sub-types →
-
Disorder of phospholipids, sphingolipids and fatty acids biosynthesis 0 trials · 15 incl. sub-types
17 sub-types
- Barth syndrome 5 trials
- Sjogren-Larsson syndrome 3 trials
- Nephrotic syndrome 14 3 trials
- Hereditary sensory and autonomic neuropathy type 1 0 trials · 2 incl. sub-types Sub-types →
- Neutral lipid storage disease 1 trial · 2 incl. sub-types Sub-types →
- 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome 0 trials
- GM3 synthase deficiency 0 trials
- PHARC syndrome 0 trials
- Sengers syndrome 0 trials
- Autosomal recessive complex spastic paraplegia due to kennedy pathway dysfunction 0 trials
- Congenital ichthyosis-intellectual disability-spastic quadriplegia syndrome 0 trials
- Fatty acid hydroxylase-associated neurodegeneration 0 trials
- Hereditary spastic paraplegia 39 0 trials Sub-types →
- Megaconial type congenital muscular dystrophy 0 trials
- Progressive encephalopathy with leukodystrophy due to DECR deficiency 0 trials
- Progressive myoclonic epilepsy type 8 0 trials
- Spinocerebellar ataxia type 38 0 trials
-
Hypolipoproteinemia 2 trials · 7 incl. sub-types
3 sub-types
- Hypobetalipoproteinemia 2 trials · 3 incl. sub-types Sub-types →
- Norum disease 2 trials
- Tangier disease 0 trials
-
Glucocorticoid resistance 3 trials
-
2 sub-types
-
CYP7B1-related disorder of oxysterol accumulation 0 trials · 2 incl. sub-types
2 sub-types
- Hereditary spastic paraplegia 5A 2 trials
- Congenital bile acid synthesis defect 3 0 trials
-
Disorder of plasmalogens biosynthesis 0 trials · 2 incl. sub-types
5 sub-types
- Rhizomelic chondrodysplasia punctata 2 trials Sub-types →
- Acyl-CoA binding domain containing protein 5 deficiency 1 trial
- Alkylglycerone-phosphate synthase deficiency 0 trials · 1 incl. sub-types Sub-types →
- Glyceronephosphate O-acyltransferase deficiency 0 trials · 1 incl. sub-types Sub-types →
- Fatty acyl-CoA reductase defects 0 trials Sub-types →
-
Inborn disorder of ketolysis 0 trials · 1 incl. sub-types
2 sub-types
-
Cortisone reductase deficiency 0 trials
2 sub-types
- Cortisone reductase deficiency 1 0 trials
- Cortisone reductase deficiency 2 0 trials
-
8 sub-types
- CHIME syndrome 0 trials
- GM3 synthase deficiency 0 trials
- Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency 0 trials
- Hyperphosphatasia-intellectual disability syndrome 0 trials Sub-types →
- Intellectual disability, autosomal recessive 53 0 trials
- Multiple congenital anomalies-hypotonia-seizures syndrome 1 0 trials
- Multiple congenital anomalies-hypotonia-seizures syndrome 2 0 trials
- Multiple congenital anomalies-hypotonia-seizures syndrome 3 0 trials
-
Lipoid proteinosis 0 trials
-
2 sub-types
- Combined pancreatic lipase-colipase deficiency 0 trials
- Pancreatic colipase deficiency 0 trials
Most studied deeper sub-types
-
Experimental drug for cholesterol and fatty liver fails to advance
Disease control Stopped earlyThis early-stage trial tested a new drug called LY3885125 in people with high cholesterol (dyslipidemia) and non-alcoholic fatty liver disease (NAFLD). The main goal was to check safety and how the body processes the drug. The study was terminated, meaning it stopped early, so it…
Phase 1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Heart drug for diabetics shows promise but trial ends early
Disease control Stopped earlyThis study tested whether pemafibrate, a drug that lowers triglycerides, could reduce heart attacks, strokes, and heart-related deaths in over 10,000 people with type 2 diabetes and high triglycerides. Participants took either pemafibrate or a placebo twice daily. The trial was t…
Phase 3 • Sponsor: Kowa Research Institute, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC